NGUYEN ANH TU enters XERIS BIOPHARMA HOLDINGS, INC. with 307.21K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 3/7/2025ACC: 0001867096-25-000045
Officer· See Remarks
Since Feb 2026
307.21K
Baseline shares
98% direct
300K
Direct ownership
1 position
150K
Derivative underlying
1 instrument
3
Security positions
7.21K indirect
Non-Derivative Holdings3
Common Stock
DirectShares owned300K
Common Stock
IndirectShares owned3.50K
Common Stock
IndirectShares owned3.71K
Total
300K direct·7.21K indirect307.21K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 300K | Direct |
| Common Stock | 3.50K | Indirect |
| Common Stock | 3.71K | Indirect |
| Total | 307.21K | 300K direct·7.21K indirect |
Derivative Holdings1
Stock Appreciation Right
DirectUnderlying security
Common Stock
Underlying shares
150K
Shares owned
N/A
Exercise price
3.76
Expiration
—
Exercise window
—
Total
Underlying
150K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Appreciation Right Direct | Common Stock | 3.76 | — | — | 150K | N/A |
| Total | 150K | 0.00 | ||||